Sequential Neo-adjuvant Chemotherapy Followed by Capecitabine Vs. Conventional Adjuvant Chemotherapy in Breast Cancer

Clinical trial NCT03011060 · UNKNOWN

Trial details

NCT number: NCT03011060
Sponsor: The First Hospital of Jilin University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Neoplasm Female

Start date: 2016-12-01
Primary completion: 2024-12-01
Enrollment: 1588

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.